159 related articles for article (PubMed ID: 35144669)
21.
Mougeot JC; Beckman MF; Langdon HC; Lalla RV; Brennan MT; Bahrani Mougeot FK
Front Microbiol; 2021; 12():794546. PubMed ID: 35116012
[TBL] [Abstract][Full Text] [Related]
22. Integrative analysis in head and neck cancer reveals distinct role of miRNome and methylome as tumour epigenetic drivers.
Mandić K; Milutin Gašperov N; Božinović K; Dediol E; Krasić J; Sinčić N; Grce M; Sabol I; Barešić A
Sci Rep; 2024 Apr; 14(1):9062. PubMed ID: 38643268
[TBL] [Abstract][Full Text] [Related]
23. ATM Pathway Is Essential for HPV-Positive Human Cervical Cancer-Derived Cell Lines Viability and Proliferation.
Abjaude W; Prati B; Munford V; Montenegro A; Lino V; Herbster S; Rabachini T; Termini L; Menck CFM; Boccardo E
Pathogens; 2022 Jun; 11(6):. PubMed ID: 35745491
[TBL] [Abstract][Full Text] [Related]
24. Interaction of HPV16 and Cutaneous HPV in Head and Neck Cancer.
Al-Soneidar WA; Harper S; Alli BY; Nicolau B
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358615
[TBL] [Abstract][Full Text] [Related]
25. SPP1 as a key gene in the lymph node metastasis and a potential predictor of poor prognosis in head and neck carcinoma.
Feng S; Yuan W; Sun Z; Guo X; Ling J; Chang A; Zhao H; Zhuo X
J Oral Pathol Med; 2022 Aug; 51(7):620-629. PubMed ID: 35822409
[TBL] [Abstract][Full Text] [Related]
26. Genetic Mutations Associated with Inflammatory Response Caused by HPV Integration in Oropharyngeal Squamous Cell Carcinoma.
Atique M; Muniz I; Farshadi F; Hier M; Mlynarek A; Macarella M; Maschietto M; Nicolau B; Alaoui-Jamali MA; da Silva SD
Biomedicines; 2023 Dec; 12(1):. PubMed ID: 38275384
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of human papillomavirus types in head and neck cancer sub-sites in the Indian population.
Gholap D; Mhatre S; Chaturvedi P; Nair S; Gheit T; Tommasino M; Dikshit R
Ecancermedicalscience; 2022; 16():1358. PubMed ID: 35510141
[TBL] [Abstract][Full Text] [Related]
28. Integrative Analysis Identified CD38 As a Key Node That Correlates Highly with Immunophenotype, Chemoradiotherapy Resistance, And Prognosis of Head and Neck Cancer.
He Z; Yue C; Chen X; Li X; Zhang L; Tan S; Yi X; Luo G; Zhou Y
J Cancer; 2023; 14(1):72-87. PubMed ID: 36605482
[TBL] [Abstract][Full Text] [Related]
29. Caspase 3 and Cleaved Caspase 3 Expression in Tumorogenesis and Its Correlations with Prognosis in Head and Neck Cancer: A Systematic Review and Meta-Analysis.
Silva FFVE; Padín-Iruegas ME; Caponio VCA; Lorenzo-Pouso AI; Saavedra-Nieves P; Chamorro-Petronacci CM; Suaréz-Peñaranda J; Pérez-Sayáns M
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233242
[TBL] [Abstract][Full Text] [Related]
30. Implications of oral dysbiosis and HPV infection in head and neck cancer: from molecular and cellular mechanisms to early diagnosis and therapy.
Constantin M; Chifiriuc MC; Mihaescu G; Vrancianu CO; Dobre EG; Cristian RE; Bleotu C; Bertesteanu SV; Grigore R; Serban B; Cirstoiu C
Front Oncol; 2023; 13():1273516. PubMed ID: 38179168
[TBL] [Abstract][Full Text] [Related]
31. Liquid Biopsy in Head and Neck Cancer: Current Evidence and Future Perspective on Squamous Cell, Salivary Gland, Paranasal Sinus and Nasopharyngeal Cancers.
Cabezas-Camarero S; Pérez-Segura P
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740523
[TBL] [Abstract][Full Text] [Related]
32. The UBC9/SUMO pathway affects E-cadherin cleavage in HPV-positive head and neck cancer.
Sabatini ME; Compagnoni M; Maffini F; Miccolo C; Pagni F; Lombardi M; Brambilla V; Lepanto D; Tagliabue M; Ansarin M; Citro S; Chiocca S
Front Mol Biosci; 2022; 9():940449. PubMed ID: 36032664
[TBL] [Abstract][Full Text] [Related]
33. Ubiquitin Carboxyl-Terminal Hydrolases and Human Malignancies: The Novel Prognostic and Therapeutic Implications for Head and Neck Cancer.
Rong C; Zhou R; Wan S; Su D; Wang SL; Hess J
Front Oncol; 2020; 10():592501. PubMed ID: 33585209
[TBL] [Abstract][Full Text] [Related]
34. Human papillomavirus genome variants and head and neck cancers: a perspective.
Combes JD; Franceschi S
Infect Agent Cancer; 2018; 13():13. PubMed ID: 29643933
[TBL] [Abstract][Full Text] [Related]
35. Trending Anti-E7 Serology Predicts Mortality and Recurrence of HPV-Associated Cancers of the Oropharynx.
Johnson L; Ha DT; Hall MB; Shoemaker G; Bevins PA; Strickley J; Demehri S; Redman RA; Joh J
J Oncol; 2022; 2022():3107990. PubMed ID: 36199787
[TBL] [Abstract][Full Text] [Related]
36. Navigating therapeutic strategies: HPV classification in head and neck cancer.
Tabatabaeian H; Bai Y; Huang R; Chaurasia A; Darido C
Br J Cancer; 2024 Apr; ():. PubMed ID: 38643337
[TBL] [Abstract][Full Text] [Related]
37. An innovative gene expression modulating strategy by converting nucleic acids into HNC therapeutics using carrier-free nanoparticles.
Liu H; Huang Y; Li Z; Han S; Liu T; Zhao Q
Front Immunol; 2023; 14():1343428. PubMed ID: 38274829
[TBL] [Abstract][Full Text] [Related]
38. The Promise of Circulating Tumor DNA in Head and Neck Cancer.
Aulakh SS; Silverman DA; Young K; Dennis SK; Birkeland AC
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740633
[TBL] [Abstract][Full Text] [Related]
39. Targeted therapy for head and neck cancer: signaling pathways and clinical studies.
Li Q; Tie Y; Alu A; Ma X; Shi H
Signal Transduct Target Ther; 2023 Jan; 8(1):31. PubMed ID: 36646686
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
